08/28/2024
3:30 PM | Nokes Rachael (Reporting)
scPharmaceuticals (Issuer)
| Form 4/A | |
08/28/2024
3:30 PM | SCHAEFFER LEONARD D (Reporting)
scPharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/15/2024
3:51 PM | ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VI LLC (Reporting)
OrbiMed Genesis GP LLC (Reporting)
scPharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/15/2024
3:47 PM | ORBIMED ADVISORS LLC (Filed by)
scPharmaceuticals (Subject)
| Form SC 13D/A | |
08/13/2024
7:58 AM | scPharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2024
7:03 AM | scPharmaceuticals (Filer)
| Form 424B5 | |
08/12/2024
5:48 AM | scPharmaceuticals (Filer)
| Form 424B5 | |
|
08/12/2024
5:08 AM | scPharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2024
3:20 PM | scPharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/14/2024
3:07 PM | scPharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/29/2024
1:34 PM | LYTTON LAURENCE W (Filed by)
scPharmaceuticals (Subject)
| Form SC 13G | |
04/26/2024
3:26 PM | scPharmaceuticals (Filer)
| Form DEFA14A | |
04/26/2024
3:16 PM | scPharmaceuticals (Filer)
| Form DEF 14A | |
04/12/2024
3:14 PM | scPharmaceuticals (Filer)
| Form PRE 14A | |
04/05/2024
11:21 AM | BlackRock Inc. (Filed by)
scPharmaceuticals (Subject)
| Form SC 13G/A | |
04/02/2024
3:15 PM | scPharmaceuticals (Issuer)
Tucker John H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/24/2024
11:15 PM | scPharmaceuticals (Filer)
| Form EFFECT | |
03/13/2024
3:49 PM | scPharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/13/2024
3:58 PM | scPharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/13/2024
3:08 PM | scPharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
3:25 PM | 5AM Ventures IV, L.P. (Filed by)
scPharmaceuticals (Subject)
| Form SC 13G/A | |
02/12/2024
5:06 AM | Rubric Capital Management LP (Filed by)
scPharmaceuticals (Subject)
| Form SC 13G | |
02/07/2024
5:55 PM | HIRSCHMAN ORIN (Filed by)
scPharmaceuticals (Subject)
| Form SC 13G/A | |
02/02/2024
11:35 AM | Cowen Financial Products LLC (Filed by)
scPharmaceuticals (Subject)
| Form SC 13G/A | |
01/22/2024
7:27 PM | scPharmaceuticals (Issuer)
Tucker John H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2024
7:28 PM | Nokes Rachael (Reporting)
scPharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
4:30 PM | scPharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/03/2024
3:31 PM | scPharmaceuticals (Issuer)
Tucker John H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2023
3:23 PM | scPharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
